一品红(300723.SZ)子公司获甲硫酸新斯的明注射液注册证书

Core Viewpoint - The company Yipinhong (300723.SZ) announced that its wholly-owned subsidiary, Guangzhou Lianrui Pharmaceutical Co., Ltd., has received the drug registration certificate for Methacholine Chloride Injection from the National Medical Products Administration [1] Group 1 - The approved product, Methacholine Chloride Injection, is indicated for use as an anticholinesterase agent [1] - The injection is used to counteract the residual muscle relaxation effects of non-depolarizing muscle relaxants at the end of surgery, as well as for conditions such as myasthenia gravis, postoperative functional bowel distension, and urinary retention [1]